Parainfluenza virus type 3 infections in hematopoetic stem cell transplant recipients: Response to ribavirin therapy

被引：38
|
作者：
Chakrabarti, S
Collingham, KE
Holder, K
Oyaide, S
Pillay, D
Milligan, DW [1 ]
机构：
[1] Birmingham Heartlands Hosp, Dept Haematol, Birmingham B9 5SS, W Midlands, England
[2] Birmingham Heartlands Hosp, Publ Hlth Lab, Birmingham B9 5SS, W Midlands, England
来源：
CLINICAL INFECTIOUS DISEASES | 2000年 / 31卷 / 06期
关键词：
D O I：
10.1086/317482
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Parainfluenza virus (PIV) infection can be a problem among hematopoetic stem cell transplant recipients. 125 patients were prospectively evaluated for respiratory viral infections. We describe 5 patients with PIV 3 infection and their response to early treatment with ribavirin.
引用
收藏
页码：1516 / 1518
页数：3
相关论文
共 50 条
  • [1] Parainfluenza Virus Infections in Lung Transplant Recipients: A Multicenter Comparison with Influenza Virus and Assessment of Ribavirin Efficacy
    De Zwart, A.
    Riezebos-Brilman, A.
    Rasoul, A.
    Luijk, B.
    Kerstjens, H.
    Gan, T.
    Alffenaar, J. C.
    Verschuuren, E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S110 - S110
  • [2] Control of an Outbreak of Human Parainfluenza Virus 3 in Hematopoietic Stem Cell Transplant Recipients
    Maziarz, Richard T.
    Sridharan, Praseeda
    Slater, Susan
    Meyers, Gabrielle
    Post, Mary
    Erdman, Dean D.
    Peret, Teresa C. -T.
    Taplitz, Randy A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : 192 - 198
  • [3] Outbreak of human parainfluenza virus 3 infections in a hematopoietic stem cell transplant population
    Cortez, KJ
    Erdman, DD
    Peret, TCT
    Gill, VJ
    Childs, R
    Barrett, AJ
    Bennett, JE
    JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (09): : 1093 - 1097
  • [4] Outcome of Human Parainfluenza Virus infection in allogeneic stem cell transplantation recipients: possible impact of ribavirin therapy
    Perez, Ariadna
    Montoro, Juan
    Chorao, Pedro
    Gomez, Dolores
    Guerreiro, Manuel
    Gimenez, Estela
    Villalba, Marta
    Sanz, Jaime
    Hernani, Rafael
    Hernandez-Boluda, Juan Carlos
    Lorenzo, Ignacio
    Navarro, David
    Solano, Carlos
    Ljungman, Per
    Pinana, Jose Luis
    INFECTION, 2024, 52 (05) : 1941 - 1952
  • [5] The Prevalence of Hepatitis E Virus Infections and Ribavirin Therapy in Heart Transplant Recipients
    Okamura, K.
    Nawata, K.
    Kimura, M.
    Kinoshita, O.
    Masuzawa, A.
    Yamauchi, H.
    Hirata, Y.
    Owada, Y.
    Oshiro, Y.
    Okamoto, H.
    Ohkohchi, N.
    Ono, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S78 - S78
  • [6] Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcome
    Nichols, WG
    Corey, L
    Gooley, T
    Davis, C
    Boeckh, M
    BLOOD, 2001, 98 (03) : 573 - 578
  • [7] Low morbidity but prolonged viral shedding characterize parainfluenza virus 3 infections in allogeneic peripheral stem cell transplant recipients.
    Aliyu, ZY
    Bordner, MA
    Henderson, DK
    Sloand, EM
    Young, NS
    Childs, R
    Bennett, J
    Barrett, J
    BLOOD, 2004, 104 (11) : 614A - 614A
  • [8] Parainfluenza virus 3 infection after stem cell transplant: Relevance to outcome of rapid diagnosis and ribavirin treatment
    Elizaga, J
    Olvarria, E
    Apperley, JF
    Goldman, JM
    Ward, KN
    CLINICAL INFECTIOUS DISEASES, 2001, 32 (03) : 413 - 418
  • [9] Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation
    Casey, J.
    Morris, K.
    Narayana, M.
    Nakagaki, M.
    Kennedy, G. A.
    BONE MARROW TRANSPLANTATION, 2013, 48 (12) : 1558 - 1561
  • [10] Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation
    J Casey
    K Morris
    M Narayana
    M Nakagaki
    G A Kennedy
    Bone Marrow Transplantation, 2013, 48 : 1558 - 1561
12345